Showing 590 results
Archival description![[H] New drug class unveiled at Imperial](/uploads/r/null/5/c/f/5cfe2690a75dea3d88e949f10bd235d53444a6cabf876c79e0c08c96e5d7dbc9/31ab3491-82f2-4f10-93f0-74d5656df0b7-_H__screencapture-englemed-co-uk-18-18apr111-tumour-new-drug-class-php-2020-12-01-08_48_01_142.jpg)
[H] New drug class unveiled at Imperial
![[I] Evotec Partnered Drug Discovery and Development](/uploads/r/null/1/e/2/1e212d9538459860906f8031c85645193d90ba79f8a7e41367f0fd2e6d0ff2ca/1b81052e-6d69-4cf0-867c-91a0648f85d6-_I__Evotec_SE_142.jpg)
[I] Evotec Partnered Drug Discovery and Development
![[B] Bramble Energy Press Coverage](/uploads/r/null/5/f/2/5f2d08b4b8d800dd61a9fcb4d5e7c4a3f5b6d41dbee0af63af10f4a850ad67c5/07ddab9c-8aa7-4036-9749-689480a766a2-_B__Bramble_Energy_Press_Coverage_142.jpg)
[B] Bramble Energy Press Coverage
![[C] ZOT - Fuel Cell Manufacturing](/uploads/r/null/d/5/5/d55b8676f3b8f35c0a6a59c3fe37f7bad91914e2694a2b093fa3b76dc70aebbf/9d9c5ce2-f101-439c-bee8-a426b4b127cf-_C__zot-co-uk-newsitem-php-2021-02-05-17_37_47_142.jpg)
[C] ZOT - Fuel Cell Manufacturing
![[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.](/uploads/r/null/f/1/b/f1bd1623cdf41cc526be4879eec4c7d5a7795f046a66b1da207ebec998b32ce6/65f52ff2-086d-491e-a3d1-110b8ccf5f1c-_B__screencapture-bloomberg-press-releases-2020-11-16-myricx-pharma-2021-03-05-09_21_38_142.jpg)
[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.
![[E] Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority.](/uploads/r/null/2/8/5/2850997dbc1a7c6f00e426fda5c34b7e9a97045a57eed4f5e252217895ad0e66/451f1af3-c518-4ac8-9e12-9fc4f903103e-_E__screencapture-hra-nhs-uk-planning-and-improving-research-application-summaries-research-summaries-saliva-diagnostics-2021-03-02-09_59_54_142.jpg)
[E] Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority.
![[G] Amazon sales page of BioMin toothpaste](/uploads/r/null/e/b/d/ebd69e569a57017d93b3948c6f95ebe5d43847552ef58aa13664225b935381fa/1908963a-db38-4229-8c50-bb5f8a257945-_G__screencapture-amazon-co-uk-toothpaste-EasyPick-support-remineralisation-cleaning-dp-B01N901QRD-2021-03-02-10_07_33_142.jpg)
[G] Amazon sales page of BioMin toothpaste
![[I] BioMin receives FDA Approval](/uploads/r/null/e/0/d/e0d10257e5ce4513c24779a688d480921b2a63732d8c13cba6b66e4e807038e6/da5393f2-0a6e-42d0-8c99-528523bf89cf-_I__screencapture-markets-businessinsider-news-stocks-dr-collins-biomin-toothpaste-receives-fda-approval-1028470492-2021-03-05-09_24_47_142.jpg)
[I] BioMin receives FDA Approval
![[E] Drax and Econic partner to produce plastic using waste CO2](/uploads/r/null/0/8/8/088840ba4bcf8e200d47d664d449fcc442ccf989b44e3af7ee2ea15db6129f02/2b0b06e4-9c45-4dca-8854-90d4e911ee0a-_E__thechemicalengineer-news-drax-and-econic-partner-2020-08-26-15_35_03_142.jpg)
[E] Drax and Econic partner to produce plastic using waste CO2
![[I] Press coverage of Econic](/uploads/r/null/a/8/7/a8752998fb1114c3d4a66fd1489a9aaf49e8f82acd46686133f4660978b76200/7dfd68b4-61db-42fd-89a8-87a9c44e481d-_I__Econic_Press_Coverage_142.jpg)
[I] Press coverage of Econic
![[B] SAGE Ebola Summary Minute of 3rd Meeting 8 December 2014](/uploads/r/null/d/d/c/ddcad618c0f052f10578ab9abd13a6836df8fea6d327c60c9dbfe81bb6fd9b90/5142c0d2-a0b2-4c11-a64e-fb51398adb22-_B__sage-ebola-minutes-8-december-2014_142.jpg)
[B] SAGE Ebola Summary Minute of 3rd Meeting 8 December 2014
![[C] UK Vaccine Network](/uploads/r/null/1/4/c/14c67457506c0580fa19cf8f837591251c4af2f67820941e70be8e17d2d68fd5/e6918759-d219-42e4-9db0-7f999ced508d-_C__gov-uk-government-groups-uk-vaccines-network-2021-02-01-12_16_48_142.jpg)
[C] UK Vaccine Network
![[D] Designing a Vaccine efficacy trial during Public Health Emergencies24 - 25 March 2016 Agenda](/uploads/r/null/d/7/6/d764acb2fe8efd728f76a8a18ecff0cbea19486f2fe47add32e6e9d2604c70ce/014f2994-ca95-4235-9457-8d335a77d9d1-_D__chamonix-agenda_142.jpg)
[D] Designing a Vaccine efficacy trial during Public Health Emergencies24 - 25 March 2016 Agenda
![[H] study-warns-swift-action-needed-to-curb-exponential-climb-in-ebola-outbreak](/uploads/r/null/e/6/8/e684b30cc28957a22e21c59fdadd0dbef0a3620cff89de0ddca06992eeab40c6/d9ceb42e-7231-4450-8b8b-d9b2420ae6e7-_H__who-int-news-item-22-09-2014-study-warns-swift-action-needed-to-curb-exponential-climb-in-ebola-outbreak-2021-02-01-12_25_14__1__142.jpg)
[H] study-warns-swift-action-needed-to-curb-exponential-climb-in-ebola-outbreak
I6-GraphicsFuzz-Acquired-ByGoogle.pdf
I9-Chrome-bugs.pdf
I13-GraphicsFuzz tests that have been added to the Vulkan CTS.pdf
I14-Debugging OpenCL Applications.pdf
I2-IXICO-Annual-Report-2019.pdf
I3-IXICO-plc-Annual-Report-2020.pdf